Inspire Medical grants 6,350 RSUs to officer

INSP’s Chief Operations and Innovation Officer received a new 6,350-RSU equity award vesting over three years.

Rhea-AI Filing Summary

Inspire Medical Systems, Inc. (symbol: INSP) is the issuer of record for a Form 4 filing submitted to the SEC. Kelly Jason P reported acquisition or exercise transactions in this Form 4 filing.

Inspire Medical Systems, Inc. (INSP) reported that Chief Operations and Innovation Officer Jason P. Kelly received an equity compensation grant of 6,350 restricted stock units on August 31, 2026. These RSUs vest in three equal annual installments starting August 31, 2027, contingent on his continued employment, bringing his directly held common shares to 25,335.

Insider Trade Summary

Grant/Award: 6,350 shares

Grant/Award 1 txn

Insider Kelly Jason P

Role See Remarks

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F1	6,350	$0.00	$0.00

Holdings After Transaction: Common Stock — 25,335 shares (Direct)

Footnotes (1)

1. F1. Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on August 31, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Key Figures

RSUs granted: 6,350 units Shares following transaction: 25,335 shares Vesting schedule: 3 equal annual installments +1 more

4 metrics

RSUs granted 6,350 units Restricted stock units awarded on August 31, 2026

Shares following transaction 25,335 shares Common shares beneficially owned after the RSU award

Vesting schedule 3 equal annual installments RSUs vest annually starting August 31, 2027, over three years

Price per share $0.00 per share Equity compensation grant, no cash paid for RSUs

Key Terms

restricted stock units ("RSUs"), vests in three equal annual installments, contingent right to receive one share, continuous employment

4 terms

restricted stock units ("RSUs") financial

"Represents an award of restricted stock units ("RSUs"), which vests in three"

Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.

vests in three equal annual installments financial

"which vests in three equal annual installments commencing on August 31, 2027"

contingent right to receive one share financial

"Each RSU represents a contingent right to receive one share of the Issuer's"

continuous employment financial

"subject to the Reporting Person's continuous employment with the Issuer"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did INSP report for Jason P. Kelly?

Inspire Medical Systems reported that Jason P. Kelly received a grant of 6,350 restricted stock units of common stock on August 31, 2026 as equity compensation, classified as a grant, award, or other acquisition.

How do the new RSUs for INSP’s officer vest?

The 6,350 RSUs vest in three equal annual installments beginning on August 31, 2027. Vesting is conditioned on Jason P. Kelly’s continuous employment with Inspire Medical Systems through each relevant vesting date.

What does each RSU granted by INSP represent?

Each restricted stock unit granted to Jason P. Kelly represents a contingent right to receive one share of Inspire Medical Systems’ common stock, subject to satisfying the vesting and continuous employment conditions.

How many INSP shares does Jason P. Kelly hold after this RSU award?

Following the RSU grant, Jason P. Kelly is reported to beneficially own 25,335 shares of Inspire Medical Systems’ common stock as a direct holding, assuming the reported post-transaction share figure reflects his direct position.

Was the INSP insider grant made under a Rule 10b5-1 trading plan?

No. The filing indicates the Rule 10b5-1 checkbox is not affirmed, and there is no footnote stating that the 6,350 RSU grant was made pursuant to a Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/02/2026 - 08:29 PM EDT Accepted by SEC EDGAR 09/02/2026 - 08:29 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kelly Jason P

(Last) (First) (Middle)

C/O INSPIRE MEDICAL SYSTEMS, INC.

5500 WAYZATA BLVD., SUITE 1600

(Street)

GOLDEN VALLEY MINNESOTA 55416

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Inspire Medical Systems, Inc. [ INSP ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	See Remarks

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/31/2026		A		6,350(1)	A	$0.00	25,335	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents an award of restricted stock units ("RSUs"), which vests in three equal annual installments commencing on August 31, 2027. Each RSU represents a contingent right to receive one share of the Issuer's common stock, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates.

Remarks:

Title - Chief Operations and Innovation Officer

	/s/ Bryan Phillips, Attorney-in-Fact for Jason P. Kelly	09/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)